What is Conduit Pharmaceuticals Inc. (CDT) stock price today?

Conduit Pharmaceuticals Inc. (CDT) currently trades at $2.25 per share. The stock has a market capitalization of $13.36M and a P/E ratio of —x.

Is CDT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Conduit Pharmaceuticals Inc. has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is —.

Is Conduit Pharmaceuticals Inc. financially healthy?

Conduit Pharmaceuticals Inc.'s Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of — places it in the —.

CDT

Conduit Pharmaceuticals Inc.

NASDAQ: CDT · HEALTHCARE · BIOTECHNOLOGY

$2.25

-8.55% today

Updated 2026-04-29

Market cap

$13.36M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1,177.89

Dividend yield

—

52W range

$2 – $1,754

Volume

0.4M

Market cap

$13.36M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1,177.89

Dividend yield

—

52W range

$2 – $1,754

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.8

Quality

3.5

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-5.64M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$922.22M	$2.72B	$2.72B
Net income	$-4.89M	$-535000.00	$-17.80M	$237.52M	$-21.32M
EPS	—	—	—	—	$-1,177.89
Free cash flow	$-2.27M	$-7.72M	$-9.73M	$-17.96M	$-5.64M
Profit margin	—	—	-1.93%	8.75%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CDT	$13.36M	17	4.3	3.5	5.0	4.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Conduit Pharmaceuticals Inc. trades at $2.25. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Conduit Pharmaceuticals Inc.'s stock price?

Conduit Pharmaceuticals Inc. (CDT) trades at $2.25.

Is Conduit Pharmaceuticals Inc. overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Conduit Pharmaceuticals Inc. (CDT)?

The analyst target price is $—, representing NaN% downside from the current price of $2.25.

Piotroski F-Score?

2/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.conduitpharma.com

Quick metrics

P/S ratio—

ROE—

Beta2.08

50D MA$11.77

200D MA$114.43

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CDT vs LLY →CDT vs JNJ →CDT vs ABBV →Stock screener →